Knowledge Distillery

COVID-19 TREATMENT In this nice narrative review just published in JAMA, the authors summarize current evidence regarding major proposed treatments,…

Stroke acute management and outcomes during the COVID-19 outbreak: A cohort study from the Madrid stroke network

The authors of this study aimed to characterise myofiber structure in the diaphragm of critically ill patients with COVID-19.

In this study, recently published in Neurology Neuroimmunology & Neuroinflammation, the authors conducted a survey on the risk of COVID-19 in patients…

In this paper recently published in Neurology, the authors aimed to determine whether neurological manifestations are common in hospitalised COVID-19…

SARS-CoV-2 has currently precipitated the COVID-19 global health crisis.

Most human monoclonal antibodies (mAbs) neutralizing SARS-CoV-2 recognize the spike (S) protein receptor-binding domain and block virus interactions…

The SARS-CoV-2 spike (S) glycoprotein contains an immunodominant receptor-binding domain (RBD) targeted by most neutralizing antibodies (Abs) in…

The objective of this matched cohort study was to establish whether there is any change in mortality from infection with a new variant of SARS-CoV-2 ,…

Whilst respiratory failure in COVID-19 arises from severe interstitial lung involvement, SARS-CoV-2 likely spreads also through the nervous system.

The impact of the COVID‐19 pandemic on PD patients is yet to be determined. Studies showed diverse prevalence and outcomes among PD patients.

Studies suggest an increased risk of adverse outcomes among patients with acute ischemic stroke (AIS) and COVID-19.